Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Thomas Shrader initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $27. Alto Neuroscience shares closed at $12.11 on Friday. See how other analysts view this stock.
- B of A Securities analyst Travis Steed initiated coverage on Masimo Corporation …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- BTIG analyst Thomas Shrader initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $27. Alto Neuroscience shares closed at $12.11 on Friday. See how other analysts view this stock.
- B of A Securities analyst Travis Steed initiated coverage on Masimo Corporation …
Full story available on Benzinga.com
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
BTIG analyst Thomas Shrader initiated coverage on Alto Neuroscience, Inc. (NYSE:ANRO) with a Buy rating and announced a price target of $27. Alto Neuroscience shares closed at $12.11 on Friday. See how other analysts view this stock.
B of A Securities analyst Travis Steed initiated coverage on Masimo Corporation …Full story available on Benzinga.com Read MoreADVM, ANRO, COCO, HPQ, MASI, News, OVID, TATT, Top Initiations, VVOS, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, COCO, US2188681074, MASI, US5747951003, HPQ, US4282361033, TATT, ADVM, OVID, VVOS, ANRO, News, Initiation, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, Benzinga Markets
